XRCC6BP1: A key player in cisplatin resistance and lung cancer stem cells

被引：0
|
作者：
Barr, M. P. [1 ,2 ]
Singh, S. [1 ,2 ]
Foley, E. [1 ,2 ]
He, Y. [1 ,2 ]
Young, V. [3 ]
Ryan, R. [3 ]
Nicholson, S. [4 ]
Leonard, N. [4 ]
O'Byrne, Kj. [5 ]
Cuffe, S. [1 ]
Finn, S. [2 ,4 ]
机构：
[1] St James Hosp, Thorac Oncol, Dublin, Ireland
[2] Trinity Coll Dublin, Dublin, Ireland
[3] St James Hosp, Cardiothorac Surg, Dublin, Ireland
[4] St James Hosp, Histopathol, Dublin, Ireland
[5] Queensland Univ Technol, Canc & Ageing Res, Brisbane, Qld, Australia
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：S1 / S2
页数：2
相关论文
共 50 条
  • [1] XRCC6BP1: A Key Player in the DNA Repair of Cisplatin Resistant NSCLC Cells
    Barr, M.
    Singh, S.
    Farrell, R.
    Foley, E.
    He, Y.
    Brady, L.
    Young, V.
    Ryan, R.
    Nicholson, S.
    Leonard, N.
    Cuffe, S.
    Finn, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1927 - S1927
  • [2] XRCC6BP1: A DNA Repair Gene in Cisplatin Resistant Lung Cancer Stem Cells That May Predict Survival Outcomes in Patients
    Barr, M.
    Farrell, R.
    Singh, S.
    Foley, E.
    He, Y.
    Brady, L.
    Young, V.
    Ryan, R.
    Nicholson, S.
    Leonard, N.
    Cuffe, S.
    Finns, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S377 - S377
  • [3] Identification and targeting of the DNA repair gene, XRCC6BP1, in cisplatin resistant NSCLC
    Barr, M. P.
    Foley, E.
    He, Y.
    Young, V.
    Ryan, R.
    Nicholson, S.
    Leonard, N.
    O'Byrne, K. J.
    Finn, S. P.
    Cuffe, S.
    LUNG CANCER, 2016, 91 : S2 - S2
  • [4] Characterization and Targeting of the DNA Repair Gene, XRCC6BP1, in Cisplatin Resistant NSCLC
    Barr, Martin
    Singh, Saravjeet
    Foley, Emma
    He, Yuexi
    Young, Vincent
    Ryan, Ronan
    Nicholson, Siobhan
    Leonard, Niamh
    Cuffe, Sinead
    O'Byrne, Kenneth
    Finn, Stephen
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S926 - S927
  • [5] XRCC6BP1: A key DNA repair gene in platinum-resistant NSCLC
    Barr, M. P.
    Foley, E.
    He, Y.
    Young, V.
    Ryan, R.
    Nicholson, S.
    Leonard, N.
    O'Byrne, K.
    Cuffe, S.
    Finn, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S89 - S89
  • [6] Elucidating the Role of XRCC6BP1 In Mitochondrial Bioenergetics and Metabolism in Non-Small Cell Lung Cancer
    Barr, M. P.
    Woods, A.
    Kirwan, G.
    Heeran, A.
    Kilgallon, A.
    Raju, A.
    Cuffe, S.
    Finn, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S443 - S443
  • [7] Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance
    Hoque, Saminur
    Dhar, Rajib
    Kar, Rishav
    Mukherjee, Sayantanee
    Mukherjee, Dattatreya
    Mukerjee, Nobendu
    Nag, Sagnik
    Tomar, Namrata
    Mallik, Saurav
    BIOMARKERS, 2023, 28 (02) : 139 - 151
  • [8] MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6
    Yang, Lawei
    Lin, Ziying
    Wang, Yahong
    Gao, Shenglan
    Li, Qinglan
    Li, Chunyan
    Xu, Wenya
    Chen, Jie
    Liu, Tie
    Song, Zeqing
    Liu, Gang
    MOLECULAR CARCINOGENESIS, 2018, 57 (03) : 419 - 428
  • [9] BCLAF1 induces cisplatin resistance in lung cancer cells
    Jiang, Tao
    Liu, Bingjie
    Wu, Dongping
    Zhang, Feng
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [10] Transcriptional Regulation as a Key Player in Cancer Cells Drug Resistance
    Martinez-Balibrea, Eva
    Ciribilli, Yari
    FRONTIERS IN ONCOLOGY, 2021, 11
12345